Skip to content

Effects of acupuncture on mental status and sleep quality in hypertensive patients with anxiety and depression: A protocol of randomized controlled trail

Effects of acupuncture on mental status and sleep quality in hypertensive patients with anxiety and depression: A protocol of randomized controlled trail

Status
Unknown
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20230228003
Enrollment
66
Registered
2023-02-28
Start date
2023-03-21
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High blood pressure is a clinically common chronic mental and physical illness, often accompanied by psychological disorders such as anxiety and depression. As a classic supplementary alternative therapy, there is evidence that acupuncture has a good effect on improving the mental state and sleep quality of people with high blood pressure and anxiety-associated depression. High blood pressure

Interventions

The acupuncture points are: Baihui(DU20), Sishencong(EX-HN1), Renying(ST9), Hegu(LI4), Taichong(LR3), Shenmen(HT7), Sanyinjiao(SP6), Xinshu(BL15), Ganshu(BL18), and Guan Yuan(BL18), and the acupunctur
s Republic of China on Meridian Point Sites
Experimental Other
Acupuncture treatment

Sponsors

Huaying Wang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 79 Years

Inclusion criteria

Inclusion criteria: (1) Patients who meet the diagnostic criteria for high blood pressure and are accompanied by anxiety and depression; (2) PSQI score > 7 points; (3) Age between 18 years and 79 years, regardless of gender; (4) Patients voluntarily participate in the trial and sign an informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with severe complications of high blood pressure and other severe organ dysfunction; (2) Patients with serious skin infections and dysfunction of blood coagulation; (3) Patients with serious mental illness; (4) Pregnant or lactating women; (5) Patients with a history of allergies to components of the drug in this study; (6) Subjects participating in clinical trials of other drugs.

Design outcomes

Primary

MeasureTime frame
PSQI score 4 weeks including 7 items, each entry is 0 to 3 points, and the higher the score, the worse the quality of sleep

Secondary

MeasureTime frame
Anxiety status assessment 4 weeks using the Generalized Anxiety Disorder (GAD-7)[17], mild: 5 to 9 points; moderate: 10 to 14 points; and severe: 15 to 21 points.

Countries

China

Contacts

Public ContactPengcheng Ren

The People's Hospital of Dazu, Chongqing, China

doctorr@163.com15696122469

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026